Back to ALXO
MARSHALL WACE, LLP ALXO Position History
ALX Oncology Holdings Inc. • Healthcare
Quarters held
24
Latest value
$3.6M
Q3 2026
Peak value
$5.5M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $79K |
| Q4 2023 | $172K |
| Q1 2024 | $1.4M |
| Q2 2024 | $703K |
| Q2 2024 | $3.1M |
| Q3 2024 | $9K |
| Q3 2024 | $282K |
| Q1 2025 | $15K |
| Q1 2025 | $154K |
| Q2 2025 | $32K |
| Q2 2025 | $13K |
| Q3 2025 | $14K |
| Q3 2025 | $59K |
| Q4 2025 | $12K |
| Q4 2025 | $18K |
| Q1 2026 | $1.1M |
| Q1 2026 | $868K |
| Q1 2026 | $5.5M |
| Q2 2026 | $32K |
| Q2 2026 | $1.3M |
| Q2 2026 | $5.1M |
| Q3 2026 | $75K |
| Q3 2026 | $705K |
| Q3 2026 | $3.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.6M | 2.59M | — | — |
| Q3 2026 | $705K | 507.4K | — | — |
| Q3 2026 | $75K | 54.3K | — | — |
| Q2 2026 | $5.1M | 2.45M | — | — |
| Q2 2026 | $1.3M | 604.4K | — | — |
| Q2 2026 | $32K | 15.6K | — | — |
| Q1 2026 | $5.5M | 2.75M | — | — |
| Q1 2026 | $868K | 434.1K | — | — |
| Q1 2026 | $1.1M | 568.1K | — | — |
| Q4 2025 | $18K | 15.6K | — | — |
| Q4 2025 | $12K | 10.8K | — | — |
| Q3 2025 | $59K | 32.0K | — | — |
| Q3 2025 | $14K | 7.6K | — | — |
| Q2 2025 | $13K | 29.9K | — | — |
| Q2 2025 | $32K | 76.4K | — | — |
| Q1 2025 | $154K | 247.7K | — | — |
| Q1 2025 | $15K | 23.5K | — | — |
| Q3 2024 | $282K | 155.1K | — | — |
| Q3 2024 | $9K | 5.0K | — | — |
| Q2 2024 | $3.1M | 519.1K | — | — |
| Q2 2024 | $703K | 116.6K | — | — |
| Q1 2024 | $1.4M | 121.5K | — | — |
| Q4 2023 | $172K | 11.6K | — | — |
| Q1 2023 | $79K | 17.6K | — | — |